HTA Course EPIB 670

EPIB-670: An Introduction to Health Technology Assessment

Course Description:

Modern health technologies, including pharmaceuticals and medical devices, have been revolutionizing health-care delivery over the last century. However, increased reliance on these technologies has been an important contributor to rising health-care costs. This has led to an interest in evidence-based decision-making to support the introduction of technologies into routine practice and evaluation of existing technologies. Health Technology Assessment (HTA) is a multi-disciplinary field that uses methods from Clinical Research, Health Economics and Health Policy to summarize evidence from research studies in a form useful to policy makers. This short course will introduce students to some of the basic concepts in health technology assessment - the need for HTA, producers of HTA, components of a HTA (systematic reviews, meta-analysis, cost-effectiveness analysis, decision making) and the impact of HTA.


URL: http://www.mcgill.ca/tau/hta-course-epib-670

Credits: 2

Prerequisites: Exposure to introductory level courses in Epidemiology and Biostatistics, preferably EPIB-601 and EPIB-607 or their equivalent.

Evaluation: Class participation and group presentation

Schedule: 9:00am-4:45pm, June 12-16 2017 (See detailed timetable below)

Location: Room #25, Purvis Hall, McGill University, Montreal

Course Instructors:

·         Nandini Dendukuri, is an Associate Professor at McGill University and the Director of the Technology Assessment Unit of the McGill University Health Centre. She holds a PhD in Biostatistics.

·         James Brophy, is a Professor at McGill University and holds the chair in Health Technology Assessment from the Fonds de Recherche du Québec (Santé). He is a practicing cardiologist with a PhD in Epidemiology.
 

Guest Speakers:

Laurie Lambert is a clinical epidemiologist and is the coordinator of the Cardiovascular Evaluation Unit at the Institut National d'Excellence en Santé et Services Sociaux (INESSS)

Alice Dragomir, is an assistant professor at the Faculty of Medicine, McGill University whose research focuses on health economics and outcomes research. She has also carried out economic evaluations for the Canadian Association for Drugs and Technologies in Health (CADTH). 

Session 1, June 12 2017, Monday

 

9-9:15

Introduction to the course

Nandini

9:15-10:30

Lecture: What is HTA? Why do we need HTA?

Jay

10:30-10:45

Break

10:45-12:15

Practical session: Planning an HTA

12:15-13:30

Break

13:30-15:00

Lecture:  Who does HTA? What is the role of HTA as a technology evolves?

Nandini

15:00-15:15

Break

15:15-16:45

Practical session: Comparing perspectives of different HTA bodies

 

Session 2, June 13 2017, Tuesday

 

9-10:30

Lecture:  Evidence from RCTs and meta-analyses

Nandini

10:30-10:45

Break

10:45-12:15

Practical session: Critiquing a published meta-analysis within an HTA.

12:15-13:30

Break

13:30-15:00

Lecture: Comparative effectiveness: Going beyond RCTs

Jay

15:00-15:15

Break

15:15-16:45

Lecture and Practical session:  The role of field evaluation               Laurie

in HTA   

   

Session 3, June 14 2017, Wednesday

 

9-10:30

Lecture:  Introduction to Economic Analysis in HTA

Nandini

10:30-10:45

Break

10:45-12:15

Practical session: Carrying out simple economic analyses using Excel software

12:15-13:30

Break

13:30-15:00

Lecture : RAMQ Drug Approval Process 

Jay

15:00-15:15

Break

15:15-16:45

Lecture and practical session:  A case study examining real-life utilization of abiraterone for prostate cancer

Alice

 

Session 4, June 15 2017, Thursday

 

9-10:30

Lecture: Writing an HTA report

Nandini

10:30-10:45

Break

10:45-12:15

Practical session: Applying GRADE guidelines to summarize the quality of evidence

 

Group Presentations, June 16 2017, Friday

 

9-10:30

Student Presentations

10:30-10:45

Break

10:45-12:15

Student Presentations